Market potential and priority patient needs
One of the challenges inhibiting a more unified and co-ordinated global action in the field of AMR product development incentives is a lack of evidence or data to quantify the need or size of the challenge and therefore the scale of the required intervention. to help address this, a Market Analysis Expert Advisory Group (EAG), with broad geographic and technical representation across the One Health continuum, was established by the Global AMR R&D Hub's Board of Members. The EAG was tasked with estimating the global market potential for products that they identified as representing some of the greatest unmet need for addressing AMR. The study outcomes will be used to inform policy makers of the scale of this part of the AMR challenge and to support current thinking on market intervention.